Predicting VHH-Fc Developability from Large-Scale IgG Data, Upcoming Webinar Hosted by Xtalks

In this free webinar, learn how predictive models trained on conventional IgG antibody data can be applied to assess VHH-Fc developability. The featured speaker will examine findings from a large-scale VHH-Fc dataset, including how accurately IgG-trained models predict different biophysical properties across antibody formats. Attendees will also explore which properties are most transferable, where predictions fall short and how model selection influences cross-format prediction performance.
TORONTO, Nov. 19, 2026 /PRNewswire/ — Predicting whether a therapeutic protein can be manufactured and formulated successfully typically requires a dedicated experimental campaign for each molecular format. However, the ability to apply existing antibody datasets across different molecular formats could improve developability assessments and inform antibody development decisions. This webinar explores the potential of cross-format predictive modeling using data from conventional IgG antibodies to assess VHH-Fc developability.
The session will introduce GDPa5, a 160-member VHH-Fc library profiled across ten standardized biophysical assays and examine whether models trained only on 559 IgGs can predict developability properties in a scaffold lacking both a light chain and a CH1 domain. Results demonstrate that 559 examples from a different antibody format can provide greater predictive value than 100 examples from the target format.
The webinar will also examine how prediction accuracy varies across biophysical properties. Transfer succeeds for properties encoded in local surface features, including heparin binding (Spearman ρ = 0.82), hydrophobicity (0.63) and self-association (0.62), but performs poorly for thermostability (0.16), which emerges from interdomain cooperativity absent in the target scaffold. The findings also highlight differences in model performance, with tabular neural networks better accommodating cross-format differences than linear and tree-based approaches.
Register for this webinar to explore how IgG data and predictive modeling can support VHH-Fc developability assessment and antibody development decisions.
Join Josh Moller, Sr. Engineer, Ginkgo Datapoints, for the live webinar on Wednesday, December 9, 2026, at 12pm EST (6pm CET / EU-Central).
For more information, or to register for this event, visit Predicting VHH-Fc Developability from Large-Scale IgG Data.
ABOUT XTALKS
Xtalks – The Life Science Community™ empowers professionals across pharma, biotech, medtech, healthcare and research with the trusted knowledge and collaborative insights that move the industry forward. Powered by Honeycomb Worldwide Inc., Xtalks delivers news, feature articles, webinars, podcasts, videos, expert interviews, curated job opportunities and more designed to support informed decision-making in a fast-evolving sector.
Every year, thousands of professionals rely on Xtalks for timely intelligence, peer perspectives and industry thought leadership. Join our life science community to stay informed, connected and ready for what’s next.
To learn more about Xtalks, visit www.xtalks.com
For information about working with Xtalks to host your webinar, visit https://xtalks.com/partner-with-us/
Contact:
Soumya Shashikumar
Tel: +1 (416) 977-6555 x371
Email: skumar@xtalks.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/predicting-vhh-fc-developability-from-large-scale-igg-data-upcoming-webinar-hosted-by-xtalks-302944868.html
SOURCE Xtalks
